Cite
HARVARD Citation
Zhu, J. et al. (2022). Clinical analysis of anlotinib as first-line treatment for elderly patients with advanced lung adenocarcinoma without driver gene mutations. Anti-cancer drugs. 33 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhu, J. et al. (2022). Clinical analysis of anlotinib as first-line treatment for elderly patients with advanced lung adenocarcinoma without driver gene mutations. Anti-cancer drugs. 33 (1), p. . [Online].